Semaglutide, already approved by the FDA as a treatment for type 2 diabetes, is a synthetic version of the naturally occurring hormone GLP-1 and works on appetite centers in the brain and the gut, producing feelings of fullness
CrossRef A Nephrologist Perspective on Obesity: From Kidney Injury to Clinical Management Clara Garca-Carro, Ander Vergara, Sheila Bermejo, Mara A
For others, metabolic effects and calorie expenditure may play a larger role
Pati S, Irfan W, Jameel A, Ahmed S, Shahid RK
Take the First Step Towards a Healthier You With Trava Health's unique, patient-centered approach to weight loss medicine in Wyoming, Michigan, you're never alone on your journey to better health
The most commonly reported side effects of retatrutide in clinical trials are gastrointestinal, including nausea, vomiting, diarrhoea, constipation, and decreased appetite, consistent with other GLP-1-based therapies